During the Trading Day
10.45 +0.01 / +0.10%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
10.45 0.00 / 0.00%
Volume: 7.6K
Health Technology

Company Description

Dyax Corp. is a biopharmaceutical company, which discovers, develops and commercializes biopharmaceuticals for unmet medical needs. The company utilizes its proprietary drug discovery technology to identify antibody, small protein and peptide compounds for clinical development. It also develops angioedema portfolio for the prophylactic treatment of hereditary angioedema and a diagnostic test to identify plasma kallikrein-mediated disorders. Dyax was founded in 1995 and is headquartered in Burlington, MA.

Contact Information

Dyax Corp.
55 Network Drive
Burlington Massachusetts 01803
P:(617) 225-2500
Investor Relations:
(617) 250-5741



Individual stakeholders8.05%
Mutual fund holders48.93%
Other institutional46.44%

Top Executives

Gustav A. ChristensenPresident, Chief Executive Officer & Director
George V. MigauskyChief Financial Officer & Executive Vice President
Burt A. AdelmanChief Medical Officer, EVP-Research & Development
Todd BazemoreChief Commercial Officer & Executive VP
Andrew D. AsheSenior Vice President & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.